Safety of electroconvulsive therapy in patients receiving dabigatran therapy.
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN.
Scott T
ST
Schmidt
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN. Electronic address: lapid.maria@mayo.edu.
Maria I
MI
Lapid
Department of Medicine, Mayo Clinic, Rochester, MN.
Karna K
KK
Sundsted
Department of Pharmacy, Mayo Clinic, Rochester, MN.
Julie L
JL
Cunningham
Department of Nursing, Mayo Clinic, Rochester, MN.
Debra A
DA
Ryan
Department of Medicine, Mayo Clinic, Jacksonville, FL.
M Caroline
MC
Burton
D000368:Aged; D000369:Aged, 80 and over; D000991:Antithrombins / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D000069604:Dabigatran / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000150:complications* / Q000628:therapy; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D006801:Humans; D008297:Male; D013923:Thromboembolism / Q000517:prevention & control
D000991:Antithrombins; D000069604:Dabigatran